Skip to content
HowShorted

Gossamer Bio, Inc. short interest in 2023

In 2023, Gossamer Bio, Inc.'s disclosed short interest ran from 28.76% of shares outstanding on 13 Jan 2023 to 7.79% on 29 Dec 2023, a change of -20.97 percentage points. The year's high was 28.76% on 13 Jan 2023 and its low 7.79% on 29 Dec 2023, averaging 15.96% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.06 days on 13 Oct 2023. Full history: Gossamer Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Gossamer Bio, Inc. in 2023

2023 in figures

Start of year
28.76% (13 Jan 2023)
End of year
7.79% (29 Dec 2023)
Change
-20.97 pp
High
28.76% (13 Jan 2023)
Low
7.79% (29 Dec 2023)
Average
15.96%
Highest days to cover
20.06 (13 Oct 2023)
SEC filings marked
8

Every report in 2023

Gossamer Bio, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202328.76%6.83
31 Jan 202326.84%7.49
15 Feb 202326.72%9.51
28 Feb 202328.18%8.11
15 Mar 202325.81%6.73
31 Mar 202317.96%2.5410-K filed, results (8-K)
14 Apr 202318.03%8.98
28 Apr 202317.14%7.30
15 May 202316.52%12.4510-Q filed, results (8-K)
31 May 202315.98%7.23
15 Jun 202317.03%5.96
30 Jun 202315.04%4.92
14 Jul 202315.37%9.09
31 Jul 202321.09%4.96
15 Aug 20239.08%13.6410-Q filed, results (8-K)
31 Aug 20238.78%13.39
15 Sep 20238.95%6.46
29 Sep 202310.58%13.21
13 Oct 202310.40%20.06
31 Oct 20238.89%6.66
15 Nov 20239.83%11.0910-Q filed, results (8-K)
30 Nov 202310.02%12.55
15 Dec 20238.35%7.43
29 Dec 20237.79%11.80

See also: Gossamer Bio, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.